Your AI-Trained Oncology Knowledge Connection!

Fabio A. Schultz, MD

Articles by Fabio A. Schultz, MD

Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic

ByAndrey Soares, MD,Fabio A. Schultz, MD,Diogo Assed Bastos, MD,Deni Leonardo Fontes Jardim, MD, PhD,Fernando Sabino Marques Monteiro, MD

September 22nd 2020

This article discusses the potential implications of using checkpoint inhibitors during the COVID-19 pandemic.

Latest Updated Articles

Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic
Published: September 22nd 2020 | Updated:

Trending on CancerNetwork

FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC

FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer

Monitoring Response to Radioligand Therapy in Prostate Cancer

KEYNOTE-B61 Trial Review

Trastuzumab Deruxtecan Regimen Accepted for Review in HER2+ Breast Cancer

© 2025 MJH Life Sciences^®

All rights reserved.